Study on Single and Multiple Atomization Inhalation of HRS-9821 Suspension for Inhalation in Healthy Subjects and COPD Patients
Clinical trial NCT05622864 · COMPLETED
Trial details
- NCT number
- NCT05622864
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2025-05-07
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.